Premium
Commentary: antibodies reacting with the infliximab Fab portion – something new? Authors' reply
Author(s) -
Nielsen C. H.,
Steenholdt C.,
Palarasah Y.,
Bendtzen K.,
Teisner A.,
Brynskov J.,
Teisner B.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12426
Subject(s) - immunogen , infliximab , medicine , antibody , generalizability theory , receiver operating characteristic , gastroenterology , immunology , tumor necrosis factor alpha , monoclonal antibody , statistics , mathematics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom